Skip to content
Dose Brief
Menu
No. 198 here · Grade C

VevaRX review

VevaRX sells compounded semaglutide at $189 a month, but offers tirzepatide only as a $467 three-month prepayment, which its own page calls $149 a month.

Visit VevaRX Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
From $189/mo (compounded)
Tirzepatide
Not disclosed
Coverage
36 states
Brand-name
Compounded only

Prices read from VevaRX's own site on . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior readingNew to the tracker on 1 September 2026, and read on the provider's own site rather than taken on trust: we checked https://vevarx.com/ on 2026-09-01 and this row reflects what that page says. The line we publish is From $189/mo (compounded). There is no earlier reading of ours to compare it against yet.

The scorecard

VevaRX scored on our six Brief Score factors. See the methodology.

Price Stability48/100
Supply Reliability73/100
Transparency88/100
Access Breadth64/100
Clinical Oversight74/100
Track Record64/100

What we like

  • Semaglutide is sold on a true month-to-month plan at a single published figure.
  • The 36 states served are listed by name in the FAQ.
  • A three-month semaglutide option is published with its total as well as its per-month equivalent.
  • The legal entity is published.
  • Prices appear before any intake rather than behind an account.

The caveats

  • Tirzepatide has no monthly option at all; the only plan is $467 for three months.
  • That plan is advertised as the equivalent of $149 a month, when $467 over three months is $155.67.
  • The semaglutide page carries two different prices for the same product, $189 a month and $167 a month.
  • The contact page's FAQ answers how to take semaglutide with instructions for mixing a scoop of a greens powder into water, and promises a refund policy the terms contradict.
  • No physical address, pharmacy, clinician or NPI number is published anywhere.

The brief

Best for: Shoppers who want semaglutide monthly and will check every figure on the page against the one in the cart. VevaRX sells compounded semaglutide at $189 a month, but offers tirzepatide only as a $467 three-month prepayment, which its own page calls $149 a month.

Ranked #198 of 536 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Before you decide

The questions readers ask next after reading about VevaRX.

Closest here

The providers scoring nearest VevaRX — the realistic shortlist if you're weighing it.

Weighing VevaRX against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs VevaRX, and every provider that outranks it is listed on the VevaRX alternatives ranking.

More providers we track (24)

505 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect VevaRX's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on VevaRX's site. Not medical advice; see our disclosure.

← Back to all rankings